Imke Metz Selected Research

Imke Metz Research Topics

Disease

30	Multiple Sclerosis 03/2023 - 05/2007
15	Demyelinating Diseases (Demyelinating Disease) 03/2023 - 05/2007
8	Progressive Multifocal Leukoencephalopathy 10/2023 - 02/2012
6	Neuromyelitis Optica (Devic's Disease) 01/2018 - 01/2012
5	Inflammation (Inflammations) 11/2021 - 08/2009
5	Immune Reconstitution Inflammatory Syndrome 01/2016 - 02/2012
3	Leukoencephalopathies 01/2021 - 01/2016
2	Infections 10/2021 - 01/2012
2	Cysts 01/2021 - 10/2016
2	Central Nervous System Diseases (CNS Diseases) 01/2020 - 01/2016
2	Drug Hypersensitivity Syndrome 09/2018 - 01/2018
2	Lymphoma (Lymphomas) 01/2018 - 11/2012
2	Relapsing-Remitting Multiple Sclerosis 01/2017 - 04/2016
2	Disease Progression 11/2015 - 05/2007
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2015 - 06/2015
2	Wallerian Degeneration 04/2013 - 09/2010
1	Stroke (Strokes) 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 10/2019
1	Meningoencephalitis 10/2019
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019
1	Tuberous Sclerosis (Bourneville's Disease) 01/2019
1	Eosinophilia 01/2018
1	Central Nervous System Vasculitis 09/2017
1	Rheumatoid Arthritis 01/2017
1	Optic Neuritis (Retrobulbar Neuritis) 01/2017
1	Glioma (Gliomas) 10/2016
1	Cerebral Small Vessel Diseases 10/2016
1	Kidney Calculi (Kidney Stone) 01/2016
1	Complementation Group B Molybdenum Cofactor Deficiency 01/2016
1	Vasculitis (Vasculitides) 01/2013
1	Encephalomyelitis (Myeloencephalitis) 01/2013

Drug/Important Bio-Agent (IBA)

10	Natalizumab (Tysabri)FDA Link 01/2023 - 02/2012
8	AntibodiesIBA 01/2018 - 01/2012
4	Daclizumab (Zenapax)FDA Link 10/2019 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2021
3	SteroidsIBA 01/2023 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 04/2013
3	Complement System Proteins (Complement)IBA 01/2020 - 01/2018
3	Immunoglobulin G (IgG)IBA 10/2016 - 01/2015
2	Monoclonal AntibodiesIBA 11/2021 - 10/2019
2	Small Nucleolar RNA (snoRNA)IBA 01/2021 - 10/2016
2	Viral AntigensIBA 01/2020 - 04/2016
2	Peptides (Polypeptides)IBA 01/2020 - 04/2016
2	AntigensIBA 01/2018 - 09/2017
2	Alemtuzumab (Campath)FDA Link 01/2018 - 01/2016
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018 - 01/2016
2	nitazoxanide (NTZ)FDA Link 01/2017 - 01/2016
2	AutoantibodiesIBA 10/2016 - 10/2016
2	FumaratesIBA 06/2015 - 06/2015
2	Maraviroc FDA Link 03/2015 - 01/2014
2	Neuropeptide Y Receptors (Neuropeptide Y Receptor)IBA 04/2013 - 09/2010
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2023
1	IntegrinsIBA 11/2021
1	Rituximab (Mabthera)FDA Link 10/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2019
1	GlucocorticoidsIBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Dimethyl FumarateIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	Aquaporins (Water Channels)IBA 01/2018
1	EnzymesIBA 01/2017
1	ImmunosorbentsIBA 01/2017
1	CytokinesIBA 01/2017
1	Coloring Agents (Dyes)IBA 01/2017
1	Interleukin-27 (Interleukin 27)IBA 01/2017
1	IronIBA 01/2017
1	MetalsIBA 01/2017
1	N-acetylglutamate 4-nitroanilide (AGNA)IBA 10/2016
1	1,3-dipropyl-8-phenylxanthineIBA 10/2016
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 10/2016
1	Semaphorin-3AIBA 10/2016
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 10/2016
1	amphiphysinIBA 10/2016
1	Glutamate Receptors (Glutamate Receptor)IBA 10/2016
1	AcidsIBA 10/2016
1	GABA Receptors (GABA Receptor)IBA 10/2016
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 10/2016
1	Inositol (Myoinositol)IBA 10/2016
1	Leucine (L-Leucine)FDA Link 10/2016
1	glutamate receptor delta 2IBA 10/2016
1	Myelin-Oligodendrocyte GlycoproteinIBA 10/2016
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 10/2016
1	Protein Kinases (Protein Kinase)IBA 10/2016
1	Epidermal Growth Factor (EGF)IBA 10/2016
1	metabotropic glutamate receptor type 1IBA 10/2016
1	molybdopterin (molybdenum cofactor)IBA 01/2016
1	SulfitesIBA 01/2016
1	XanthineIBA 01/2016
1	Retinaldehyde (Retinal)IBA 01/2015
1	Aquaporin 4IBA 04/2014
1	Amyloid (Amyloid Fibrils)IBA 04/2013
1	HLA-DR Antigens (HLA-DR)IBA 04/2013

Therapy/Procedure

14	Therapeutics 10/2023 - 02/2012
2	Plasma Exchange 01/2018 - 03/2012
1	Subcutaneous Injections 01/2018
1	Aftercare (After-Treatment) 01/2018
1	Blood Component Removal (Apheresis) 01/2018